Regular ArticleSubcutaneous Rotenone Exposure Causes Highly Selective Dopaminergic Degeneration and α-Synuclein Aggregation
References (65)
- et al.
Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats
Behav. Brain Res.
(2002) - et al.
Metabolic compromise with systemic 3-nitropropionic acid produces striatal apoptosis in Sprague–Dawley rats but not in BALB/c ByJ mice
Exp. Neurol.
(1998) - et al.
Titrating the effects of mitochondrial complex I impairment in the cell physiology
J. Biol. Chem.
(1999) Inhibitors of NADH-ubiquinone reductase: An overview
Biochim. Biophys. Acta
(1998)- et al.
Systemic administration of rotenone produces selective damage in the striatum and globus pallidus, but not in the substantia nigra
Brain Res.
(1997) - et al.
alpha-Synuclein promotes mitochondrial deficit and oxidative stress
Am. J. Pathol.
(2000) - et al.
Uptake of MPP+ by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTP
Eur. J. Pharmacol.
(1984) - et al.
Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation
Neuroscience
(2000) - et al.
Membrane-bound alpha-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form
J. Biol. Chem.
(2002) - et al.
Formation and removal of alpha-synuclein aggregates in cells exposed to mitochondrial inhibitors
J. Biol. Chem.
(2001)
The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation: A novel mechanism of toxicity
J. Biol. Chem.
(2000)
The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice
J. Biol. Chem.
(2002)
Novel free radical spin traps protect against malonate and MPTP neurotoxicity
Exp. Neurol.
(1999)
Parkinson's disease, pesticides, and glutathione transferase polymorphisms
Lancet
(1998)
Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease
Biochem. Biophys. Res. Commun.
(1989)
Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin. 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine
Life Sci.
(1985)
Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: Implications for neuroprotection studies
Neuroscience
(2000)
Mitochondrial complex I deficiency in Parkinson's disease
Lancet
(1989)
Coenzyme Q10 and nicotinamide and a free radical spin trap protect against MPTP neurotoxicity
Exp. Neurol.
(1995)
Chronic reduction in complex I function alters calcium signaling in SH-SY5Y neuroblastoma cells
Brain Res.
(2001)
Dityrosine cross-linking promotes formation of stable alpha-synuclein polymers: Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies
J. Biol. Chem.
(2000)
The differential vulnerability of striatal projection neurons in 3-nitropropionic acid-treated rats does not match that typical of adult-onset Huntington's disease
Exp. Neurol.
(2002)
Increased striatal dopamine turnover following acute administration of rotenone to mice
Brain Res.
(2000)
Alpha-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome
FEBS Lett.
(2001)
Pesticides directly accelerate the rate of alpha-synuclein fibril formation: A possible factor in Parkinson's disease
FEBS Lett.
(2001)
A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease
J. Neurochem.
(1997)
Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid
J. Neurosci.
(1993)
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Nat. Neurosci.
(2000)
Topological analysis of striatal lesions induced by 3-nitropropionic acid in the Lewis rat
NeuroReport
(2001)
Mitochondrial respiratory chain activity in skeletal muscle from patients with Parkinson's disease
Neurology
(1993)
Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct
Science
(2001)
Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease
J. Neurochem.
(1989)
Cited by (608)
Benzoic-D5 acid as D<inf>2</inf> receptor agonist in the treatment of rotenone induced Parkinson's disease in mice
2023, Arabian Journal of ChemistryBi-directional regulation of AIMP2 and its splice variant on PARP-1-dependent neuronal cell death; Therapeutic implication for Parkinson's disease
2024, Acta Neuropathologica Communications
- 1
These authors contributed equally to this work.
Copyright © 2002 Elsevier Science (USA). All rights reserved.